US Stock MarketDetailed Quotes

BPMC Blueprint Medicines

Watchlist
  • 91.950
  • +0.690+0.76%
Trading Feb 26 13:29 ET
5.88BMarket Cap-85.93P/E (TTM)

Blueprint Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
104.04%508.82M
103.41%146.37M
126.61%128.18M
139.98%138.16M
51.87%96.12M
22.22%249.38M
85.55%71.96M
-14.26%56.57M
57.52%57.57M
0.89%63.29M
Operating revenue
103.89%508.45M
102.92%145.99M
126.61%128.18M
139.98%138.16M
51.87%96.12M
22.22%249.37M
85.52%71.95M
-14.26%56.57M
57.52%57.57M
0.89%63.29M
Cost of revenue
136.10%20.16M
2,764.23%7.45M
-30.55%1.93M
226.86%7.59M
0.50%3.19M
-52.06%8.54M
-94.64%260K
-7.27%2.78M
-52.46%2.32M
-37.49%3.18M
Gross profit
102.90%488.66M
93.76%138.92M
134.74%126.25M
136.33%130.56M
54.59%92.93M
29.33%240.84M
111.29%71.7M
-14.60%53.78M
74.50%55.25M
4.27%60.11M
Operating expense
-3.07%700.71M
1.85%180.12M
-3.19%175.23M
-4.61%173.61M
-6.16%171.75M
1.13%722.86M
-2.75%176.85M
-2.48%180.99M
-2.76%181.99M
14.25%183.02M
Selling and administrative expenses
21.73%359.27M
21.60%96.45M
27.12%89.93M
24.20%89.34M
17.77%83.56M
24.34%295.14M
23.89%79.32M
22.80%70.74M
22.57%71.93M
24.35%70.95M
-Selling and marketing expense
80.30%96.6M
58.33%30.23M
104.58%26.74M
99.77%22.71M
68.46%16.93M
--53.58M
--19.09M
69.34%13.07M
18.10%11.37M
--10.05M
-General and administrative expense
8.74%262.67M
9.96%66.23M
9.56%63.19M
10.02%66.63M
9.40%66.63M
--241.56M
--60.23M
15.60%57.67M
23.44%60.56M
--60.9M
Research and development costs
-20.17%341.43M
-14.21%83.67M
-22.63%85.3M
-23.43%84.27M
-21.31%88.19M
-10.41%427.72M
-17.23%97.54M
-13.85%110.25M
-14.33%110.06M
8.67%112.07M
Operating profit
56.01%-212.04M
60.82%-41.2M
61.50%-48.97M
66.04%-43.05M
35.87%-78.82M
8.81%-482.02M
28.91%-105.15M
-3.75%-127.21M
18.49%-126.75M
-19.87%-122.91M
Net non-operating interest income expense
-49.80%-28.15M
-50.42%-7.78M
-100.00%-7.62M
-71.77%-6.86M
-1.31%-5.9M
-12.08%-18.79M
44.06%-5.17M
54.65%-3.81M
-1,035.83%-4M
-1,416.52%-5.82M
Non-operating interest income
23.90%40.66M
5.68%10.39M
19.52%11.15M
28.22%9.94M
55.56%9.18M
--32.81M
--9.83M
216.24%9.33M
1,689.61%7.75M
--5.9M
Non-operating interest expense
33.33%68.81M
21.10%18.17M
42.85%18.77M
43.04%16.8M
28.62%15.07M
--51.61M
--15M
15.79%13.14M
195,650.00%11.75M
--11.72M
Other net income (expense)
3,451.25%174.33M
42.48%-306K
123.49%587K
100.91%17K
56,240.00%174.03M
25.09%-5.2M
-20.09%-532K
-96.93%-2.5M
-22.93%-1.86M
91.66%-310K
Earnings from equity interest
--0
--0
--0
--0
--0
52.44%-4.26M
102.40%45K
-6.37%-1.77M
42.47%-1.23M
60.31%-1.3M
Special income (charges)
--173.68M
--0
--0
--18K
--173.66M
--0
--0
--0
--0
--0
-Less:Other special charges
---173.68M
--0
----
---18K
---173.66M
----
----
----
----
----
Other non- operating income (expenses)
169.34%656K
46.97%-306K
180.63%587K
99.84%-1K
-61.87%376K
-147.21%-946K
-140.38%-577K
-283.84%-728K
-199.05%-626K
317.66%986K
Income before tax
86.98%-65.86M
55.54%-49.28M
58.06%-56M
62.37%-49.89M
169.22%89.32M
8.38%-506.02M
29.66%-110.86M
-0.94%-133.52M
15.31%-132.6M
-21.95%-129.04M
Income tax
26.65%1.23M
1,001.64%672K
38.58%273K
-46.32%102K
-65.38%180K
-81.51%968K
-94.11%61K
-77.77%197K
-93.93%190K
182.61%520K
Net income
86.77%-67.09M
54.96%-49.96M
57.91%-56.28M
62.35%-49.99M
168.80%89.14M
9.06%-506.98M
30.09%-110.92M
-0.41%-133.71M
16.85%-132.79M
-22.23%-129.56M
Net income continuous Operations
86.77%-67.09M
54.96%-49.96M
57.91%-56.28M
62.35%-49.99M
168.80%89.14M
9.06%-506.98M
30.09%-110.92M
-0.41%-133.71M
16.85%-132.79M
-22.23%-129.56M
Minority interest income
Net income attributable to the parent company
86.77%-67.09M
54.96%-49.96M
57.91%-56.28M
62.35%-49.99M
168.80%89.14M
9.06%-506.98M
30.09%-110.92M
-0.41%-133.71M
16.85%-132.79M
-22.23%-129.56M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
86.77%-67.09M
54.96%-49.96M
57.91%-56.28M
62.35%-49.99M
168.80%89.14M
9.06%-506.98M
30.09%-110.92M
-0.41%-133.71M
16.85%-132.79M
-22.23%-129.56M
Basic earnings per share
87.22%-1.07
56.59%-0.79
59.55%-0.89
63.47%-0.8
167.44%1.45
10.48%-8.37
31.32%-1.82
1.35%-2.2
18.28%-2.19
-20.11%-2.15
Diluted earnings per share
87.22%-1.07
56.59%-0.79
59.55%-0.89
63.47%-0.8
165.12%1.4
10.48%-8.37
31.32%-1.82
1.35%-2.2
18.28%-2.19
-20.11%-2.15
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 104.04%508.82M103.41%146.37M126.61%128.18M139.98%138.16M51.87%96.12M22.22%249.38M85.55%71.96M-14.26%56.57M57.52%57.57M0.89%63.29M
Operating revenue 103.89%508.45M102.92%145.99M126.61%128.18M139.98%138.16M51.87%96.12M22.22%249.37M85.52%71.95M-14.26%56.57M57.52%57.57M0.89%63.29M
Cost of revenue 136.10%20.16M2,764.23%7.45M-30.55%1.93M226.86%7.59M0.50%3.19M-52.06%8.54M-94.64%260K-7.27%2.78M-52.46%2.32M-37.49%3.18M
Gross profit 102.90%488.66M93.76%138.92M134.74%126.25M136.33%130.56M54.59%92.93M29.33%240.84M111.29%71.7M-14.60%53.78M74.50%55.25M4.27%60.11M
Operating expense -3.07%700.71M1.85%180.12M-3.19%175.23M-4.61%173.61M-6.16%171.75M1.13%722.86M-2.75%176.85M-2.48%180.99M-2.76%181.99M14.25%183.02M
Selling and administrative expenses 21.73%359.27M21.60%96.45M27.12%89.93M24.20%89.34M17.77%83.56M24.34%295.14M23.89%79.32M22.80%70.74M22.57%71.93M24.35%70.95M
-Selling and marketing expense 80.30%96.6M58.33%30.23M104.58%26.74M99.77%22.71M68.46%16.93M--53.58M--19.09M69.34%13.07M18.10%11.37M--10.05M
-General and administrative expense 8.74%262.67M9.96%66.23M9.56%63.19M10.02%66.63M9.40%66.63M--241.56M--60.23M15.60%57.67M23.44%60.56M--60.9M
Research and development costs -20.17%341.43M-14.21%83.67M-22.63%85.3M-23.43%84.27M-21.31%88.19M-10.41%427.72M-17.23%97.54M-13.85%110.25M-14.33%110.06M8.67%112.07M
Operating profit 56.01%-212.04M60.82%-41.2M61.50%-48.97M66.04%-43.05M35.87%-78.82M8.81%-482.02M28.91%-105.15M-3.75%-127.21M18.49%-126.75M-19.87%-122.91M
Net non-operating interest income expense -49.80%-28.15M-50.42%-7.78M-100.00%-7.62M-71.77%-6.86M-1.31%-5.9M-12.08%-18.79M44.06%-5.17M54.65%-3.81M-1,035.83%-4M-1,416.52%-5.82M
Non-operating interest income 23.90%40.66M5.68%10.39M19.52%11.15M28.22%9.94M55.56%9.18M--32.81M--9.83M216.24%9.33M1,689.61%7.75M--5.9M
Non-operating interest expense 33.33%68.81M21.10%18.17M42.85%18.77M43.04%16.8M28.62%15.07M--51.61M--15M15.79%13.14M195,650.00%11.75M--11.72M
Other net income (expense) 3,451.25%174.33M42.48%-306K123.49%587K100.91%17K56,240.00%174.03M25.09%-5.2M-20.09%-532K-96.93%-2.5M-22.93%-1.86M91.66%-310K
Earnings from equity interest --0--0--0--0--052.44%-4.26M102.40%45K-6.37%-1.77M42.47%-1.23M60.31%-1.3M
Special income (charges) --173.68M--0--0--18K--173.66M--0--0--0--0--0
-Less:Other special charges ---173.68M--0-------18K---173.66M--------------------
Other non- operating income (expenses) 169.34%656K46.97%-306K180.63%587K99.84%-1K-61.87%376K-147.21%-946K-140.38%-577K-283.84%-728K-199.05%-626K317.66%986K
Income before tax 86.98%-65.86M55.54%-49.28M58.06%-56M62.37%-49.89M169.22%89.32M8.38%-506.02M29.66%-110.86M-0.94%-133.52M15.31%-132.6M-21.95%-129.04M
Income tax 26.65%1.23M1,001.64%672K38.58%273K-46.32%102K-65.38%180K-81.51%968K-94.11%61K-77.77%197K-93.93%190K182.61%520K
Net income 86.77%-67.09M54.96%-49.96M57.91%-56.28M62.35%-49.99M168.80%89.14M9.06%-506.98M30.09%-110.92M-0.41%-133.71M16.85%-132.79M-22.23%-129.56M
Net income continuous Operations 86.77%-67.09M54.96%-49.96M57.91%-56.28M62.35%-49.99M168.80%89.14M9.06%-506.98M30.09%-110.92M-0.41%-133.71M16.85%-132.79M-22.23%-129.56M
Minority interest income
Net income attributable to the parent company 86.77%-67.09M54.96%-49.96M57.91%-56.28M62.35%-49.99M168.80%89.14M9.06%-506.98M30.09%-110.92M-0.41%-133.71M16.85%-132.79M-22.23%-129.56M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 86.77%-67.09M54.96%-49.96M57.91%-56.28M62.35%-49.99M168.80%89.14M9.06%-506.98M30.09%-110.92M-0.41%-133.71M16.85%-132.79M-22.23%-129.56M
Basic earnings per share 87.22%-1.0756.59%-0.7959.55%-0.8963.47%-0.8167.44%1.4510.48%-8.3731.32%-1.821.35%-2.218.28%-2.19-20.11%-2.15
Diluted earnings per share 87.22%-1.0756.59%-0.7959.55%-0.8963.47%-0.8165.12%1.410.48%-8.3731.32%-1.821.35%-2.218.28%-2.19-20.11%-2.15
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Lantheus
LNTH
+18.59%
Hutchmed (China)
HCM
+6.77%
Workday
WDAY
+6.70%
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
+2.24%
DexCom
DXCM
+1.58%

Unlock the Full List

Investment Theme Cancer Research
Cancer Research
Intraday-1.69%